Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diagnostic Challenge

Objective:Mistake in diagnosis Background:Marginal zone lymphoma is a low-grade, B-cell, non-Hodgkin lymphoma.Bone marrow involvement (BMI) of leukemia or lymphoma can usually be displayed in fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) with high standardized uptake values (SUV), while diffuse homogeneous 18 F-FDG bone marrow uptake (BMU) in PET/CT primarily reflects hyperplastic bone marrow status.This report is of a 74-year-old man presenting with anemia and a diagnosis of recurrent marginal zone lymphoma with bone marrow involvement identified with 18 F-FDG PET/CT imaging and biopsy. Case Report:A 64-year-old man with severe anemia and body weight loss of 7 kg in 1 month was diagnosed with marginal zone lymphoma, stage III, in July 2011.He went into complete remission in April 2012 after 6 cycles of chemotherapy, with Hb restored.Anemia and diffuse homogeneous 18 F-FDG BMU in PET/CT were then noted during a routine check-up in October 2021, and recurrent disease was established through positive biopsy of subcutaneous nodules and bone marrow.Subsequent complete remission after 6 cycles of combination therapy was validated with pathologically negative BMI, the resolution of the slightly enhanced 18 F-FDG BMU in PET/CT, and restored hemoglobin. Conclusions:This report has highlighted the importance of follow-up for patients with lymphoma and supports the diagnostic role of 18 F-FDG PET/CT imaging and the pathological verification in identifying malignant involvement in bone marrow.